Cell Source, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)
Cell Source, Inc. (CLCS) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) of -$80.88 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-07-29.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease · last filed 2024-07-29
- Cell Source, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2024-03-31 was -$80.88K.
- Cell Source, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2023-09-30 was $49.76K, a 47.27% increase year-over-year.
- Cell Source, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2023-06-30 was $27.34K, a 8.03% decline year-over-year.
- Cell Source, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2023-03-31 was -$47.23K, a 242.26% decline year-over-year.
- Cell Source, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2023 was -$159.17K, a 258.74% decline from fiscal 2022.
- Cell Source, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2022 was $100.27K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2024-03-31 | -$80.88K 10-Q · filed 2024-07-29 | |||
| 2023-12-31 | -$159.17K 10-K · filed 2024-06-24 | |||
| 2023-09-30 | $49.76K 10-Q · filed 2023-11-09 | $77.10K derived: sum of 2 quarters · filed 2023-11-09 | $29.88K derived: sum of 3 quarters · filed 2024-07-29 | |
| 2023-06-30 | $27.34K 10-Q · filed 2023-11-09 | -$19.88K derived: sum of 2 quarters · filed 2024-07-29 | ||
| 2023-03-31 | -$47.23K 10-Q · filed 2024-07-29 | |||
| 2022-12-31 | $100.27K 10-K · filed 2024-06-24 | |||
| 2022-09-30 | $33.79K 10-Q · filed 2023-11-09 | $63.52K derived: sum of 2 quarters · filed 2023-11-09 | $96.72K derived: sum of 3 quarters · filed 2023-11-09 | |
| 2022-06-30 | $29.73K 10-Q · filed 2023-11-09 | $62.93K derived: sum of 2 quarters · filed 2023-11-09 | ||
| 2022-03-31 | $33.20K 10-Q · filed 2023-11-09 | |||
| 2021-03-31 | $41.70K 10-Q · filed 2021-05-17 |